Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Tesamorelin (Primary)
- Indications HIV-associated lipodystrophy syndrome
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 03 May 2014 Status changed from active, no longer recruiting to completed.
- 06 Mar 2014 Primary endpoint 'Magnetic-resonance-imaging-outcomes' has been met.